CHEMOTHERAPY VS IMMUNOTHERAPY AS NEOADJUVANT THERAPIES IN CISPLATIN-ELIGIBLE PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Nocera, Luigi
Bandini, Marco
Basile, Giuseppe
Moschini, Marco
Naidu, Shreyas
Rose, Kyle
Li, Roger
Spiess, Philippe
Necchi, Andrea
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD44-06
引用
下载
收藏
页码：E1126 / E1127
页数：2
相关论文
共 50 条
  • [21] Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer
    Sekar, Rishi R.
    Irani, Sarosh
    Maganty, Avinash
    Montgomery, Jeffrey S.
    Herrel, Lindsey A.
    UROLOGY, 2024, 191 : 79 - 84
  • [22] Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Alva, Ajjai S.
    Tallman, Christopher T.
    He, Chang
    Hussain, Maha H.
    Hafez, Khaled
    Montie, James E.
    Smith, David C.
    Weizer, Alon Z.
    Wood, David
    Lee, Cheryl T.
    CANCER, 2012, 118 (01) : 44 - 53
  • [23] Neoadjuvant Chemotherapy Prior to Radical Cystectomy for Muscle-Invasive Bladder Cancer With Variant Histology
    Vetterlein, Malte W.
    Wankowicz, Stephanie A. M.
    Seisen, Thomas
    Lander, Richard
    Loppenberg, Bjorn
    Chun, Felix K. -H.
    Menon, Mani
    Sun, Maxine
    Barletta, Justine A.
    Choueiri, Toni K.
    Bellmunt, Joaquim
    Quoc-Dien Trinh
    Preston, Mark A.
    CANCER, 2017, 123 (22) : 4346 - 4355
  • [24] NEOADJUVANT CHEMOTHERAPY PRIOR TO RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER WITH VARIANT HISTOLOGY
    Vetterlein, Malte W.
    Mullane, Stephanie
    Seisen, Thomas
    Lander, Richard
    Loppenberg, Bjorn
    Choueiri, Toni K.
    Bellmunt, Joaquim
    Menon, Mani
    Kibel, Adam S.
    Quoc-Dien Trinh
    Preston, Mark A.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E431 - E431
  • [25] GEMCITABINE PLUS CISPLATIN NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY FOR THE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER: 9 YEARS RETROSPECTIVE ANALYSIS
    Chen, Haige
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A202 - A202
  • [26] Optimal timing of radical cystectomy after neoadjuvant chemotherapy in muscle invasive bladder cancer (MIBC)
    Parasramka, Saurabh
    Veedu, Janeesh Sekkath
    Chen, Quan
    Huang, Bin
    Wang, Peng
    Myint, Zin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [27] Incidental prostate cancer in patients undergoing radical cystectomy for muscle invasive bladder cancer
    Lindenmeir, T.
    Liehr, U. B.
    Rau, O.
    Reiher, F.
    Allhoff, E. P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 220 - 220
  • [28] Residual CIS after neoadjuvant chemotherapy and radical cystectomy for muscle invasive bladder cancer: Implications for neoadjuvant trials
    Gabrielson, Andrew T.
    Daniels, Marcus J.
    Rowe, Julian
    Alam, Ridwan
    Lee, Esther J.
    Matoso, Andres
    De Felice, Anthony
    Hahn, Noah
    Hoffman-Censits, Jean
    Bivalacqua, Trinity J.
    Kates, Max
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (04) : 164.e9 - 164.e16
  • [29] A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer
    Freiha, F
    Reese, J
    Torti, FM
    JOURNAL OF UROLOGY, 1996, 155 (02): : 495 - 499
  • [30] A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy
    Klinga, Gustaf
    Sherif, Amir
    SPRINGERPLUS, 2016, 5
12345